Page last updated: 2024-10-27

gemfibrozil and Diabetic Nephropathies

gemfibrozil has been researched along with Diabetic Nephropathies in 2 studies

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research Excerpts

ExcerptRelevanceReference
"Fifteen normotensive NIDDM patients with hypertriglyceridaemia (> 2."2.68Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus? ( Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; van Eeden, AE; Weijers, RN, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calkin, AC1
Giunti, S1
Jandeleit-Dahm, KA1
Allen, TJ1
Cooper, ME1
Thomas, MC1
Smulders, YM1
van Eeden, AE1
Stehouwer, CD1
Weijers, RN1
Slaats, EH1
Silberbusch, J1

Trials

1 trial available for gemfibrozil and Diabetic Nephropathies

ArticleYear
Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?
    European journal of clinical investigation, 1997, Volume: 27, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dise

1997

Other Studies

1 other study available for gemfibrozil and Diabetic Nephropathies

ArticleYear
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:9

    Topics: Animals; Apolipoproteins E; Collagen Type IV; Creatinine; Diabetic Nephropathies; Disease Models, An

2006